In higher organisms, the immune system consists of the innate and adaptive (or acquired) systems.
Current strategies in treating infection aim to reduce inflammation by using proinflammatory molecule inhibitors and/or by inhibiting bacterial proliferation using antibiotics.
The prognosis of critical patients is closely related to their inflammatory status and the extent and duration of the inflammatory response.
Inflammation, involved not just in inflammatory diseases (such as gastroenteritis or hepatitis) but also in the pathogenesis of obesity, diabetes and neurological diseases, contributes to the genesis and progression of cancer.
Observational studies have associated low plasma levels of omega-3 polyunsaturated fatty acids (PUFAs) with an increase in inflammation and depressive states.